期刊文献+

雷贝拉唑治疗十二指肠球部溃疡的疗效观察 被引量:15

Observation on Curative Effect of Rabeprazole Treating Duodenal Bulbar ulcer
下载PDF
导出
摘要 目的 观察雷贝拉唑治疗十二指肠球部溃疡的疗效。方法 十二指肠球部溃疡患者随机,开放式服用雷贝拉唑10 mg/d,2周,记录治疗前和用药期间的腹痛、腹胀、厌食、嗳气、反酸的变化情况。结果 十二指肠球部溃疡的治愈率92.50%,第7天上腹痛、腹胀、厌食、嗳气、反酸的缓解率分别为98.15%、93.33%、85.37%、88.00%、100.00%。结论 雷贝拉唑对十二指肠球部溃疡,能够很好控制症状,完全愈合溃疡。具有起效快、疗效稳定长久、药物相互作用小、副作用少等优点,是治疗消化性溃疡特别是十二指肠球部溃疡的一个理想的新一代质子泵抑制剂。 Objective To observe the curative effect of rabeprazole used for treating duodenal bulbay ulcer.Method To randomly select patients of dudenal bulbar ulcer, who will take the rabeprazole 10 mg per day in an opening way as long as two weeks;and to record the changes of abdominal pain,abdominal disten-tion,anorexia,smelly air from stomach and increased production of acid before the treatment and during the medicine - taking period. Results The cure rate of duodenal bulbar ulcer was 92.50% .On the 7th medicine - taking day,the release rate of abdominal pain,abdominal distention,anorexia,smelly air from stomach and increased production of acid reached 98.15%, 93.33%, 85.37%, 88.00%, and 100%, respectively . Conclusion The rabeprazole was able to control the symptoms of duodenal blubar ulcer well, so as to completely cure the ulcer.The rabeprazole featured fast effectiveness, stable curative effect, little reciprocity and few side - effects. The rabeprazole was the ideal new - generation of proton - pump stayer for treating duodenal bulbar ulcer.
出处 《疾病监测》 CAS 2004年第6期211-212,共2页 Disease Surveillance
关键词 雷贝拉唑 治疗 十二指肠球部溃疡 疗效观察 Rebeprazole Duodenal Bulbar ulcer proton - pump stayer
  • 相关文献

参考文献8

  • 1Katz PO. Anderson C, Khoury R, et al. Gastro- oesophageal reflex associated with nocturnal gastrie acid breakthrough on proton punp inhibitors[J]. Aliment Pharmacol Ther 1998, 12:1231 - 1234.
  • 2Williams MP, Sercombe J, Hamilton MI, et al. Aplacebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric and plasma gastrin concentrations in young healthy male subjects [J]. Aliment Pharmacol Ther 1998,12:1079-1089.
  • 3Yasuda S, Horai Y, Tomono Y, et al. Comparison of the kinetic disposition and metabolism of E3810, a new proton punp inhibitor, and omeprazole in relation to S - mephenytoin 4i - hydroxylation staus [J]. Clinic Pharmacol Ther 1995, 9:363 -378.
  • 4Sohn D-R,Kwon J-T, Kim H-K, et al. Metabolic disposition of lansoprazole in relation to the S- mephnytoin 4i-hydroxylation phenotype status[J]. Clinic Pharmacol Ther 1997,61:574 - 582.
  • 5Tanaka M, Ohkubo T, Otani K, et al. Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S -mephenytoin 4' - hydroxylation phenotype and genotype[J].Clinic Pharmacol Ther 1997, 62:619-628.
  • 6雷贝拉唑多中心临床观察协作组.雷贝拉唑对十二指肠球部溃疡的一日抑酸效果[J].中华内科杂志,2002,41(8):554-555. 被引量:39
  • 7牛春燕,罗金燕,朱有玲,王学勤.雷贝拉唑首次单剂量口服的抑酸效应对比研究[J].胃肠病学和肝病学杂志,2003,12(2):183-185. 被引量:8
  • 8郭建强,柯美云,王智凤.单次口服雷贝拉唑与奥美拉唑对健康人昼夜胃内pH的影响[J].中华内科杂志,2002,41(5):342-343. 被引量:72

二级参考文献8

  • 1Stedman CA, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther, 2000,14:963-978.
  • 2Sachs G, Shin JM, Briving C, et al. The pharmacology of the gastric acid pump: the H+,K+ ATPase. Annu Rev Pharmacol Toxicol,1995,35:277-305.
  • 3Williams MP, Pounder RE. Review article :the pharmacology of rabeprazole. Aliment Pharmacol Ther, 1999,13 Suppl 3 :3-10.
  • 4Besancon M, Simon A, Sachs G, et al. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents. J Biol Chem,1997,272:22438-22446.
  • 5Stedman CA,Barclay ML.Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors[].Alimentary Pharmacology and Therapeutics.2000
  • 6Dammann HG,Burkhardt F.Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion[].European Journal of Gastroenterology and Hepatology.1999
  • 7龚均,朱有玲,罗金燕,王学勤.法莫替丁单剂量肌肉注射抑制胃酸效应的观察[J].中华内科杂志,1998,37(11):762-763. 被引量:8
  • 8郭建强,柯美云,王智凤.单次口服雷贝拉唑与奥美拉唑对健康人昼夜胃内pH的影响[J].中华内科杂志,2002,41(5):342-343. 被引量:72

共引文献109

同被引文献31

引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部